Galenfeha, Inc. (GLFH), a design, engineering and
manufacturing firm focused on stored energy solutions, has signed an exclusive
agreement with Control Equipment, Inc. (“CEI”) to distribute Galenfeha
production and stored energy product lines, including its LiFePO4 battery
systems, iWaV systems, and ultra-high precision chemical injection pumps.
For more than 60 years, CEI has been a top distributor for
some of the leading manufacturers in oil and gas equipment, operating five
facilities throughout West Texas, where it will be Galenfeha’s exclusive
supplier.
Lucien Marioneaux, Jr., Galenfeha’s president and CEO
commented, “CEI’s tenure in the industry speaks to its quality products and
customer service. We are delighted they will now represent us in West Texas,
and look forward to a highly successful partnership.”
Galenfeha also noted that the distributorship agreement
reaffirms management’s commitment to continued revenue growth. The company also
forecast that increased market acceptance of its products will drive
third-quarter revenues above all previous quarters.
For more information visit www.galenfeha.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment